- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
AUXL Market Currents
more »
-
Friday 12:51 PM Watson Pharmaceuticals (WPI -0.1%) says it's filed an application with the FDA to market a generic version of Auxilium Pharmaceuticals (AUXL +1.1%) Testim 1% gel, a testosterone replacement therapy.
Comment![Healthcare]
AUXL in Focus
more »
AUXL Related Articles
more »
AUXL News
more »
-
at CNBC.com (Jan 9, 2012)
-
at MarketWatch.com (Oct 31, 2011)
-
at MarketWatch.com (Aug 1, 2011)
-
at MarketWatch.com (Jan 10, 2011)
-
at MarketWatch.com (Jan 10, 2011)
AUXL Press Releases and Filings
more »
-
PR Newswire (Thu, 7:00AM)
-
PR Newswire (Mon, 7:00AM)
-
PR Newswire (Mon, 7:00AM)
-
PR Newswire (May 17, 2012)
-
PR Newswire (May 11, 2012)
AUXL Latest Transcript
more »
AUXL Cramer
more »
Currently, there are no Cramer articles on AUXL.
AUXL Instablog posts
more »
AUXL vs. ETF Alternatives
Company Description
We are a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons who focus on... More
